RENAL PROTEOGLYCANS--EFFECTS OF DIABETES AND HYPERTROPHY

肾蛋白聚糖——糖尿病和肥大的影响

基本信息

  • 批准号:
    3239884
  • 负责人:
  • 金额:
    $ 16.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1987
  • 资助国家:
    美国
  • 起止时间:
    1987-09-30 至 1991-08-31
  • 项目状态:
    已结题

项目摘要

The overall objective of this proposal is to investigate the effects of growth and hormonal controls on proteoglycan synthesis in isolated rat renal glomeruli and tubules. Proteoglycans have recently been identified as key components of the basement membrane layer of the glomeruli and tubules. Heparan sulfate is the predominant proteoglycan in the basement membrane and has been implicated to have a critical role in the maintenance of the selective permeability function of the glomerulus, where it serves as an anionic charge barrier to plasma proteins. This permeability barrier is compromised in diabetes mellitus and certain nephrotic syndromes and this alteration is a primary pathological consequence of these conditions. Renal hypertrophy is an early consequence of the diabetic state in animals and humans and may be the initiating factor in the resulting renal pathology, but virtually nothing is known about the effects of growth, and insulin and insulin-like growth factors (IGF's) on renal proteoglycan synthesis. We have recently demonstrated the presence of receptors for insulin and IGF's in glomeruli and tubules and the known anabolic effects of these hormones and particularly the implication of the IGF's as sulfation factors point to their possible involvement in the control of proteoglycan synthesis in the kidney. We are therefore proposing to compare the types and amounts of proteoglycans synthesized in vitro by renal glomeruli and tubules and to dissect the growth effects from the hormonal controls involved in this process. Two animals models will be used: (1) the uninephrectomized rat in which the remnant kidney undergoes a rapid hypertrophy and (2) the streptozotocin-diabetic rat in which early hypertrophy occurs in the absence of circulating insulin. Isolated glomeruli and tubles from normal, diabetic ard uninephrectomized animals will be incubated with 35SO4=, 3H-glucosamine and 3H-galactose with or without insulin and IGF's and the labeled proteoglycans from the cell cytoplasm, cell membrane, basement membrane and incubation medium will be isolated and characterized to define the biosynthetic process in these tissues under different growth and hormonal stimuli. Possible controls on proteoglycan synthesis such as substrate availability, protein and carbohydrate phosphorylation and level of transferase activities will also be examined. It is anticipated that these studies will provide a metabolic basis for the control of renal proteoglycan biosynthesis in growth and disease states.
本提案的总体目标是调查其影响

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Distinct receptors for insulin-like growth factor I in rat renal glomeruli and tubules.
大鼠肾小球和肾小管中胰岛素样生长因子 I 的不同受体。
  • DOI:
    10.1152/ajpendo.1988.255.4.e504
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Pillion,DJ;Haskell,JF;Meezan,E
  • 通讯作者:
    Meezan,E
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELIAS MEEZAN其他文献

ELIAS MEEZAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELIAS MEEZAN', 18)}}的其他基金

CELLULAR ACTION OF ALKYLGLYCOSIDES AS GLYCOGEN PRIMERS
烷基糖苷作为糖原引物的细胞作用
  • 批准号:
    2693192
  • 财政年份:
    1998
  • 资助金额:
    $ 16.66万
  • 项目类别:
CELLULAR ACTION OF ALKYLGLYCOSIDES AS GLYCOGEN PRIMERS
烷基糖苷作为糖原引物的细胞作用
  • 批准号:
    2906131
  • 财政年份:
    1998
  • 资助金额:
    $ 16.66万
  • 项目类别:
CELLULAR ACTION OF ALKYLGLYCOSIDES AS GLYCOGEN PRIMERS
烷基糖苷作为糖原引物的细胞作用
  • 批准号:
    6177757
  • 财政年份:
    1998
  • 资助金额:
    $ 16.66万
  • 项目类别:
RENAL PROTEOGLYCANS--EFFECTS OF DIABETES AND HYPERTROPHY
肾蛋白聚糖——糖尿病和肥大的影响
  • 批准号:
    3239883
  • 财政年份:
    1987
  • 资助金额:
    $ 16.66万
  • 项目类别:
RENAL PROTEOGLYCANS--EFFECTS OF DIABETES AND HYPERTROPHY
肾蛋白聚糖——糖尿病和肥大的影响
  • 批准号:
    3239882
  • 财政年份:
    1987
  • 资助金额:
    $ 16.66万
  • 项目类别:
RENAL PROTEOGLYCANS--EFFECTS OF DIABETES AND HYPERTROPHY
肾蛋白聚糖——糖尿病和肥大的影响
  • 批准号:
    3239880
  • 财政年份:
    1987
  • 资助金额:
    $ 16.66万
  • 项目类别:
ROLE OF SULFATION IN THE PATHOLOGY OF CYSTIC FIBROSIS
硫酸化在囊性纤维化病理学中的作用
  • 批准号:
    3233201
  • 财政年份:
    1987
  • 资助金额:
    $ 16.66万
  • 项目类别:
ROLE OF SULFATION IN THE PATHOLOGY OF CYSTIC FIBROSIS
硫酸化在囊性纤维化病理学中的作用
  • 批准号:
    3233203
  • 财政年份:
    1987
  • 资助金额:
    $ 16.66万
  • 项目类别:
ROLE OF SULFATION IN THE PATHOLOGY OF CYSTIC FIBROSIS
硫酸化在囊性纤维化病理学中的作用
  • 批准号:
    3233195
  • 财政年份:
    1987
  • 资助金额:
    $ 16.66万
  • 项目类别:
ROLE OF SULFATION IN THE PATHOLOGY OF CYSTIC FIBROSIS
硫酸化在囊性纤维化病理学中的作用
  • 批准号:
    3233202
  • 财政年份:
    1987
  • 资助金额:
    $ 16.66万
  • 项目类别:

相似海外基金

Complete inhibition of ROCK signaling in diabetic nephropathy
完全抑制糖尿病肾病中的 ROCK 信号传导
  • 批准号:
    23K07709
  • 财政年份:
    2023
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel therapeutic approach for diabetic nephropathy by nucleic acid medicine (DNA aptamer).
开发核酸药物(DNA 适体)治疗糖尿病肾病的新方法。
  • 批准号:
    23K07732
  • 财政年份:
    2023
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Single Cell Landscape of Early Human Diabetic Nephropathy
早期人类糖尿病肾病的单细胞景观
  • 批准号:
    10765844
  • 财政年份:
    2023
  • 资助金额:
    $ 16.66万
  • 项目类别:
The analysis of the pathophysiology of MR activation-mediated diabetic nephropathy and the exploration of its novel therapeutic approaches.
MR激活介导的糖尿病肾病的病理生理学分析及其新治疗方法的探索。
  • 批准号:
    22K20914
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Dual Oxidase 2 as a New Target for Treatment of Diabetic Nephropathy
双氧化酶2作为糖尿病肾病治疗新靶点
  • 批准号:
    10624760
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
The gut-renal axis in diabetic nephropathy mediated by segmented filamentous bacteria
分节丝状菌介导的糖尿病肾病肠肾轴
  • 批准号:
    22K17768
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Dual Oxidase 2 as a New Target for Treatment of Diabetic Nephropathy
双氧化酶2作为糖尿病肾病治疗新靶点
  • 批准号:
    10334036
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
The Single Cell Landscape of Early Human Diabetic Nephropathy
早期人类糖尿病肾病的单细胞景观
  • 批准号:
    10368354
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
Development of a scoring system for predicting diabetic nephropathy severity using urinary podocyte markers.
开发使用尿足细胞标记物预测糖尿病肾病严重程度的评分系统。
  • 批准号:
    22K07448
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cytosine methylation predicts diabetic nephropathy progression
胞嘧啶甲基化预测糖尿病肾病进展
  • 批准号:
    nhmrc : 2003401
  • 财政年份:
    2021
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Ideas Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了